Astec LifeSciences Limited reported audited standalone cash flow results for the year ended March 31, 2016. For the year, the company reported net cash flow from operating activities of INR 92,288,793 compared with INR 31,509,596 a year ago. Purchase of fixed assets/capital expenditure was INR 260,488,720 compared with INR 157,687,974 a year ago.